Changes of protein oxidation, calpain and cytoskeletal proteins (alpha tubulin and pNF-H) levels in rat brain after nerve agent poisoning

Toxicology Letters

Volumn 203, Issue 3, 2011, Pages 227-236

  RamaRao, Golime ^a   Acharya, J N ^a   Bhattacharya, B K ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Acetylcholinesterase; Calpain; Cytoskeletal proteins; Immunoreactivity; Neurotoxicity; Organophosphorus nerve agents

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA TUBULIN; BRAIN PROTEIN; CALPAIN 1; SARIN; SOMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; MOLECULAR WEIGHT; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; OXIDATION; PHOSPHORYLATION; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; BRAIN CHEMISTRY; CALPAIN; CHEMICAL WARFARE AGENTS; CHOLINESTERASES; FEMALE; NEUROFILAMENT PROTEINS; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEINS; RATS; RATS, WISTAR; SARIN; SOMAN; TUBULIN;

RATTUS;

EID: 79955965612     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.03.020     Document Type: Article

References (61)

1. Abou-Donia M.B. The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chem. Biol. Interact. 1993, 87:383-393.
2. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch. Environ. Health. 2003, 58:484-497.
3. Abu-Qare A.W., Abou-Donia M.B. Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrotyrosine and 8-hydroxy-2-deoxyguanosine, biomarkers of oxidative stress. Toxicol. Lett. 2001, 123:51-58.
4. Baillle V., Doreandeu F., Carpentier P., Bizot J.-C., Filliat P., Four E., Denis J., Lallement G. Acute exposure to a low or mild dose of soman: biochemical, behavavioral and histopathological effects. Pharm. Biochem. Behav. 2001, 69:561-569.
5. Balali-Mood M., Shariat M. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. J. Physiol. Paris 1998, 92:375-378.
6. Bansal Iti., Waghmare C.K., Anand T., Gupta A.K., Bhattacharya B.K. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostistigmine. J. Appl. Toxicol. 2009, 29:386-394.
7. Benton, B.J., Sommerville, D.R., Scotto, J., Burnett, D.C., Gaviola, B.I., Crosier, R.B., Jakubowski, E.M., Whalley, C.E., Anthony, J.S., Hulet, S.W., Dabisch, P.A., Reutter, S.A., Forster, J.S., Mioduszewski, R.J., Thomson, S.A., 2005. Low level effects of VX vapor exposure on pupil size and cholinesterase levels in rats. US Government Technical Report ECBC-TR-428.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Camins A., Verdaguer E., Folch J., Pallàs M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 2006, 12(2):135-148.
10. Choudhary S., Joshi K., Gill K.D. Possible role of enhanced microtubule phosphorylation in dichlorvos induced delayed neurotoxicity in rat. Brain Res. 2001, 897:60-70.
11. Cho T.M., Castiglioni E.T. Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in sy5y neuroblastoma cells. J. Toxicol. Environ. Health Part A 2004, 67:987-1000.
12. Dabisch P.A., Michael S., Horsmon J.T., Taylor W.T., Muse D.B., Miller D.R., Sommerville R.J., Mioduszewski, Thomson S. Gender difference in the miotic potency of soman vapor in rats. Cutan. Ocul. Toxicol. 2008, 27:123-133.
13. Dalle-Donne I., Scaloni A., Giustarini D., Cavarra E., Tell G., Lungarella G., Colombo R., Rossi R., Milzani A. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom. Rev. 2005, 24:55-99.
14. Damodaran T.V., Mecklai A.A., Abou-Donia M.B. Sarin causes altered time course of mRNA expression of alpha tubulin in the central nervous system of rats. Neurochem. Res. 2002, 27(3):177-181.
15. Damodaran T.V., Bilska M.A., Rahman M.A., Abou-Donia M.B. Sarin causes early differential alteration and persistent over expression in mRNAs coding for glial fibrillary acidic protein (GFAP) and vimentin genes in the central nervous system of rats. Neurochem. Res. 2002, 27(5):407-415.
16. Damodaran T.V., Patel A.G., Greenfield S.T., Dressman H.K., Lin S.M., Abou-Donia M.B. Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure. Biochem. Pharmacol. 2006, 71:497-520.
17. Davies M.J. The oxidative environment and protein damage. Biochim. Biophys. Acta 2005, 1703:93-109.
18. Dillman J.F., Phillips C.S., Kniffin D.M., Tompkins C.P., Hamilton T.A., Kan R.K. Gene expression profile of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman. Chem. Res. Toxicol. 2009, 18:28-34.
19. Due A.H., Trap H.C., Langenberg J.P., Benschop H.P. Toxicokinetics of soman sterioisomers after subcutenaneous administration to atropinized guinea pigs. Arch. Toxicol. 1994, 68:60-68.
20. Ellman G.L., Courtney K.D., Andres V., Feather Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
21. Fournier A.E., McKeracher L. Tubulin expression and axonal transport in injured and regulatory neurons in the mammalian central nervous system. Biochem. Cell Biol. 1995, 73:659-664.
22. Gearhart D.A., Sickles D.W., Buccafusco J.J., Prendergast M.A., Terry A.V. Chlorpyrifos, chlorpyrifos-oxon and diisopropyl-fluorophosphate inhibit kinesin-dependent microtubule motility. Toxicol. Appl. Pharmacol. 2007, 218:20-29.
23. Golomb B. Acetylcholinesterase inhibitors and GulfWar illnesses. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4295-4300.
24. Grigoryan H., Li B., Anderson E.K., Xue W., Nachon F., Lockridge O., Schopfer L.M. Covalent binding of the organophosphorus agent FP-biotin to tyrosine in eight proteins that have no active site serine. Chem. Biol. Interact. 2009, 180:492-498.
25. Grigoryan H., Schopfer L.M., Peeples E.S., Duysen E.G., Grigoryan M., Thompson C.M., Lockridge O. Mass spectrometry identifies multiple organophosphorylated sites on tubulin. Toxicol. Appl. Pharmacol. 2009, 240:149-158.
26. Grigoryan H., Schopfer L.M., Thompson C.M., Terry A.V., Masson P., Lockridge O. Mass spectrometry identifies covalent binding of soman, sarin, chlorpyrifos oxon, diisopropyl fluorophosphate, and FP-biotin to tyrosines on tubulin: a potential mechanism of long term toxicity by organophosphorus agents. Chem. Biol. Interact. 2008, 175:180-186.
27. Gupta R.P., Abou-Donia M.B. In vivo and in vitro effects of diisopropylfluoridate (DFP) on the rate of hen brain tubulin polmerization. Neurochem. Res. 1994, 19:435-444.
28. Gupta R.P., Abou-Donia M.B. Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins of the hen sciatic nerve. Brain Res. 1995, 677:161-166.
29. Gupta R.P., Abou-Donia M.B. Tau phosphorylation by diisopropyl phosphorofluoridate (DFP)-treated hen brain supernatant inhibits its binding with microtubules: role of Ca2+/Calmodulin-dependent protein kinase II in tau phosphorylation. Arch. Biochem. Biophys. 1999, 365:268-278.
30. Jacobsson S.O., Cassel G.E., Persson S.A. Increased levels of nitrogen oxides and lipid peroxidation in the rat brain after soman-induced seizures. Arch. Toxicol. 1999, 73:269-273.
31. Jhonson G.V., Guttman R.P. Calpains: intact and active. Bioessay 1997, 19:1011-1018.
32. Julien J.P. Neurofilament functions in health and disease. Curr. Opin. Neurobiol. 1999, 554-560.
33. Kamel F., Engel L.S., Gladen B.C., Hoppin J.A., Alavanja M.C., Sandler D.P. Neurologic symptoms in licensed pesticide applicators in the agricultural health study. Hum. Exp. Toxicol. 2007, 26:243-250.
34. Kassa J., Pecka M., Tichy M., Bajgar J., Koupilova M., Herink J., Krocova Z. Toxic effects of sarin in rats at three months following single and repeated low-level inhalation exposure. Pharmacol. Toxicol. 2001, 88:209-219.
35. Klaidman L.K., Adams J.D., Cross R., Pazdernik T.L., Fsamson Alterations in brain glutathione homeostasis induced by the nerve gas soman. Neurotox. Res. 2003, 5(3):177-182.
36. Lariviere R.C., Julien J.P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 2004, 58(1):131-148.
37. Liem R.K. Molecular biology of neuronal intermediate filaments. Curr. Opin. Cell Biol. 1993, 5:12-16.
38. Liu J., Liu M.C., Wang K.K.W. Calpain in the CNS: from synaptic function to neurotoxicity. Sci. Signal. 2008, 1(April (4)). (pre1).
39. Liu Q., Xie F., Siedlak S.L., Nunomura A., Honda K., Moreira P.I., Zhua X., Smith M.A., Perry G. Neurofilament proteins in neurodegenerative diseases. Cell. Mol. Life Sci. 2004, 61(24):3057-3075.
40. LoPachin R.M., He D., Reid M.L. 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. Neurotoxicology 2005, 26:229-240.
41. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21:559-579.
42. Milatovic S.Z., Gupta R.C., Aschner M., Milatovic D. Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol. Appl. Pharmacol. 2009, 240(October (2)):124-131.
43. Mioduszewski, R.J., Manthei, J.H., Way, R.A., Burnett, D.C., Gaviola, B.P., Muse, W.T., Thomson, S.A., Sommerville, D.R., Crosier, R.B., Scotto, J.A., McCaskey, D.A., Crouse, C.L., Matson, K.L., 2002. Low-level sarin vapor exposure in rats: effect of exposure concentration and duration on pupil size. US Government Technical Report ECBCTR-235.
44. Milatovic D., Gupta R.C., Aschner M. Anticholinesterase toxicity and oxidative stress. Sci. World J. 2006, 6:295-310.
45. Miyaki K., Nishiwaki Y., Maekawa K., Ogawa Y., Asukai N., Yoshimura K., Etoh N., Matsumoto Y., Kikuchi Y., Kumagai N., Omae K. Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack. J. Occup. Health 2005, 47:299-304.
46. Nixon R.A., Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurochem. Sci. 1991, 14:501-506.
47. Ohbu S., Yamashina A., Takasu N., Yamaguchi T., Murai T., Nakano K., Mastui T., Mikami R., Sakurai K., Hinohara S. Sarin poisoning on Tokyo subway. South Med. J. 1997, 90.
48. Prendergast M.A., Self R.L., Smith K.J., Ghayoum L., Mullins M.M., Butler T.R., Buccafusco J.J., Gearhart D.A., Terry A.V. Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicity. Neuroscience 2007, 146:330-339.
49. Raheja G., Gill K.D. Calcium homeostasis and dichlorovos induced neurotoxicity in rat brain. Mol. Cell. Biochem. 2002, 232:13-18.
50. RamaRao G., Waghmare C.K., Srivastava N., Bhattacharya B. Regional alterations of JNK3 and CaMKII {alpha} subunit expression in the rat brain after soman poisoning. Hum. Exp. Toxicol. 2010, (Epub ahead of print).
51. RamaRao, G., Waghmare, C.K, Gupta, A.K., Bhattacharya, B.K. Soman-induced alterations of Protein Kinase C isozymes expression in five discrete areas of the rat brain. Drug Chem. Toxicol., in press.
52. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calpain in the brain in Alzheimer's disease: a potential molecular basis for neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 1999, 390:2628-2632.
53. Salvi R.M., Lara D.R., Ghisolfi E.S., Portela L.V., Dias R.D., Souza D.O. Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides. Toxicol. Sci. 2003, 72:267-271.
54. Shih T.M., Duniho S.M., McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol. Appl. Pharm. 2003, 188:69-80.
55. Solberg Y., Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 1997, 18:183-185.
56. Somani S.M., Solana R.P., Dube S.N. Toxicodynamics of nerve agents. Chemical Warfare Agents 1992, 67. Academic Press, San Diego, CA. S.M. Somani (Ed.).
57. Song F., Yan Y., Zhao X., Zhang C., Xie K. Neurofilaments degradation as an early molecular event in tri-ortho-cresylphosphate (TOCP) induced delayed neuropathy. Toxicology 2009, 258:94-100.
58. Stadtman E.R. Protein oxidation and aging. Science 1992, 257:1220-1224.
59. Steck T.L., Kant J.A. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol. 1974, 31(Pt A):172-180.
60. Terry A.V., Gearhart D.A., Beck W.D., Truan J.N., Middlemore M.L., Williamson L.N., Bartlett M.G., Prendergast M.A., Sickles D.W., Buccafusco J.J. Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing. J. Pharmacol. Exp. Ther. 2007, 322:1117-1128.
61. Vallano M.L., Buckholz T.M., DeLorenzo R.J. Phosphorylation of neurofilament proteins by endogenous calcium/calmodulin-dependent protein kinase. Biochem. Biophys. Res. Commun. 1985, 130:957-963.